Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1671584 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $4.13Day +3.77%Mkt cap $5M1Y −92.1%Off 52W high −92.2%Vol (1Y) 98.1%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,510 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest11.0% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+0.27% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$13.0M |
| Earnings (TTM)-$26.3M |
| ROE−234.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−56.2% |
| 1Y−92.1% |
| 3Y−100.0% |
| 5Y−100.0% |
| 10Y−100.0% |
| Since incept. (ann.)−75.1% |
Price return through 2026-07-30 · series begins 2016-07-20. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)98.1% |
| Ann. volatility (3Y)149.7% |
| Sharpe (1Y)−2.10 |
| Sharpe (3Y)−1.90 |
| Max drawdown (1Y)−92.5% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)2.55 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 19,638 | $84,000 | 1.66% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 13,337 | $56,948 | 1.13% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 12,713 | $54,285 | 1.08% | new |
| VANGUARD FIDUCIARY TRUST CO | 4,142 | $17,686 | 0.35% | new |
| UBS Group AG | 3,445 | $14,710 | 0.29% | +1926.5% |
| OSAIC HOLDINGS, INC. | 360 | $1,535 | 0.03% | +0.0% |
| SBI Securities Co., Ltd. | 109 | $465 | 0.01% | +251.6% |
| CWM, LLC | 5 | $21 | 0.00% | −16.7% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | −$6.41 | — | — | — |
| 2025-09-30 | 2025-11-06 | — | — | — | — |
| 2025-06-30 | 2025-08-11 | — | — | — | — |
| 2025-03-31 | 2025-05-15 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
